Stefaan De Koker

Title: Stefaan De Koker: Innovator in Lipid Nanoparticle Technology

Introduction

Stefaan De Koker is a notable inventor based in Niel, Belgium. He has made significant contributions to the field of lipid nanoparticles, particularly in their application for immunogenic delivery of nucleic acid molecules. His work is particularly relevant in the context of developing vaccines for cancer and infectious diseases.

Latest Patents

Stefaan De Koker holds a patent related to lipid nanoparticles. The invention focuses on lipid nanoparticles (LPN) that comprise an ionisable lipid, a phospholipid, a sterol, a PEG lipid, and one or more nucleic acids. These lipid nanoparticles are characterized by a minimal average diameter of about 140 nm, which enhances their ability to induce a potent immune response. The patent outlines the use of these LNPs for the immunogenic delivery of nucleic acid molecules, specifically mRNA, making them highly suitable for vaccine development.

Career Highlights

Throughout his career, Stefaan De Koker has worked with various organizations, including Etherna Immunotherapies NV and Vrije Universiteit Brussel. His experience in these institutions has allowed him to advance his research and contribute to the field of immunotherapy.

Collaborations

Stefaan has collaborated with notable colleagues such as Sanne Bevers and Peter Tomme. These partnerships have played a crucial role in his research endeavors and the development of innovative solutions in the field of lipid nanoparticles.

Conclusion

Stefaan De Koker is a pioneering inventor whose work in lipid nanoparticles has the potential to revolutionize vaccine development. His contributions to immunogenic delivery systems are significant and highlight the importance of innovation in addressing global health challenges.